DESIGN, OPTIMIZATION, AND STATISTICAL EVALUATION OF ORAL RECONSTITUTED SUSPENSION OF CLARITHROMYCIN USING ION-EXCHANGE RESINS

  • KOMAL S Department of Pharmaceutics, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India.
  • HARIKRISHNAN N Department of Pharmaceutics, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India.

Abstract

Objectives: The objective of the present study is taste masking of bitter clarithromycin using Indion 204, Indion 234, and Tulsion 335 as ion-exchange resins, which forms insoluble complexes, inhibiting the drug release in saliva as ion-exchange resins are cross-linked polymers, water-insoluble that contains salt-forming groups in repeating positions on the polymer chain. Drugs that are bitter and cationic get adsorbed onto weak cationic exchange resins of carboxylic acid functionality such as Indion 204, Indion 234, and Tulsion 335 to form non-bitter complexes.


Methods: The drug-resin complex loading process was optimized for the resin content, activation, swelling time, stirring time, influence of pH, and temperature for maximum drug loading and the formed complex was evaluated by differential scanning calorimetry (DSC) to confirm complex formation. The drug-resin complex was also characterized by their micromeritic and rheological properties. These complexes were used to prepare oral reconstituted suspensions and the taste was evaluated. The formulation was evaluated for various parameters such as sedimentation volume, pH, redispersibility, viscosity, drug content, and in vitro drug release.


Results: Acid-activated resins comprising Indion 204, Indion 234, and Tulsion 335 with the drug:resin ratio of 1:2, stirred in a solution of pH 7–8 at 70° for 6 h had a maximum drug loading and masked the bitter taste of clarithromycin. DSC of the drug-resin complex (DRC) revealed that there was interaction leading to complex formation. The drug-resin complex was formulated into suspension formulations (S1-S9) and evaluated. Various parameters were found to be within permissible limits. Formulations S3, S6, and S9 containing 1:2 ratios of the drug-resin complex of Indion 204, Indion 234, and Tulsion 335 revealed maximum taste masking. This was further confirmed by treatment of taste evaluation scores obtained from the volunteers by ANOVA, Dunnett’s multiple comparison test, and Tukey’s multiple comparison test. All the three optimized formulations had a significant difference of p<0.001 when compared to control S10. S6 formulation was widely accepted.


Conclusion: Ion-exchange complexation could efficiently mask the bitter taste of clarithromycin and achieve palatable taste suitable for pediatric use.

Keywords: Ion-exchange resins, Drug-resin complex, Taste masking, Indion 204, 234, Tulsion 335, Dunnett’s test, Tukey’s test, ANOVA

References

1. Sharma S, Lewis S. Taste masking technologies: A review. Int J Pharm Pharm Sci 2010;2:6-13.
2. Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: Recent developments and approaches. Drug Dev Ind Pharm 2004;30:429-48.
3. Roy GM, editor. Modifying Bitterness: Mechanism, Ingredients, and Applications. Boca Raton, Florida: CRC Press; 1997.
4. Borodkin S, Sundberg DP. Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets. J Pharm Sci 1971;60:1523-7.
5. Borodkin S, Yunker MH. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. J Pharm Sci 1970;59:481-6.
6. Rajesh MA, Bhatt SA, Ramana GV, Brahmbhatt H, Gajjar K, Tripathi CR, et al. Taste masking by functional cross-linked copolymers and sustain release of drug through interpenetrating polymer network with sodium alginate and k-carreganeen biopolymers. Int J Pharm Pharm Sci 2014;6:352-9.
7. Anand V, Kandarapu R, Garg S. Ion-exchange resins: Carrying drug delivery forward. Drug Discov Today 2001;6:905-14.
8. Borodkin S. Ion exchange resins delivery systems. In: Tarcha PJ, editors. Polymers for Drug Delivery. 1st ed. Boca Raton: CRC Press; 1991. p. 215-30.
9. Venkateswaramurthy N, Sambathkumar R, Vijayabaskaran M, Perumal P. Clarithromycin mucoadhesive microspheres for anti- Helicobacter pylori therapy: Formulation and in vitro evaluation. Int J Curr Pharm Res 2010;2:24-7.
10. Lu MY, Borodkin S, Woodward L, Li P, Diesner C, Hernandez L, et al. A polymer carrier system for taste masking of macrolide antibiotics. Pharm Res 1991;8:706-12.
11. Yu X, Liu H, Sun C, Shi S, Fu X, He Y. A simple and novel method for preparing the taste masking levofloxacin microsphere suspension. Afr J Pharm Pharmacol 2012;6:1617-24.
12. Goyal A, Singhvi I. Visible spectrophotometric methods for estimation of clarithromycin from tablet formulation. Indian J Pharm Sci 2006;68:656-7.
13. Helmy A, Kady ES, Khames A, Abd-elbary A. Preparation, characterization and in-vitro/vivo evaluation of Indion-based chewable tablets of paracetamol and ibuprofen for pediatric use. J Am Sci 2011;7:831-44.
14. Yewale CP, Rathi MN, Kore GG, Jadhav GV, Wagh MP. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of chlorpheniramine maleate using ion-exchange resins. Pharm Dev Technol 2013;18:367-76.
15. Dahima R, Sharma R. Comparitive study of ion exchange resin Indion 204 and Indion 214 for taste masking of metoclopramide hydrochloride and formulation of rapid disintegrating tablets. Asian J Pharm 2010;4:110-5.
16. Jain DK, Darwhekar GN, Choudhary N. Formulation and evaluation of reconstitutable oral suspension of ambroxol HCl and azithromycin. Int J PharmTech Res 2011;3:741-6.
17. Shanbhag PP, Bhalerao SS. Development and evaluation of oral reconstitutable systems of cephalexin. Int J PharmTech Res 2010;2:502-6.
18. Sana S, Rajani A, Sumedha N, Mahesh B. Formulation and evaluation of taste masked oral suspension of dextromethorphan hydrobromide. Int J Drug Dev Res 2012;4:159-72.
19. Devrim B, Bozkir A, Canefe K. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded eudragit microspheres. Acta Pol Pharm 2011;68:593-9.
20. Ishizaka T, Okada S, Takemoto E, Tokuyama E, Tsuji E, Mukai J, et al. The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder. Chem Pharm Bull (Tokyo) 2007;55:1452-7.
21. Oza N, Sagar S. Design and optimization of pediatric cefuroxime axetil dispersible tablet containing ion-exchange resin. Int J Appl Pharm 2019;11:325-32.
22. Pawar HA, Joshi PR. Development and evaluation of taste masked granular formulation of satranidazole by melt granulation technique. J Pharm 2014;2014:1-7.
23. Tavakoli N, Ghodrati M, Ghassemi-Dehkordi N, Sadeghi-Aliabadi H. Formulation and evaluation of a new herbal tablet from strawberry and grape leaves. Jundishapur J Nat Pharm Prod 2008;3:19-25.
24. Dasankoppa FS, Komal S, Sholapur HN, Nanjundaswamy NG, Sajjanar VM. Design, optimization and evaluation of chewable tablets of clarithromycin using ion exchange resins. Indian J Pharm Sci 2016;78:818-26.
Statistics
97 Views | 111 Downloads
Citatons
How to Cite
S, K., and H. N. “DESIGN, OPTIMIZATION, AND STATISTICAL EVALUATION OF ORAL RECONSTITUTED SUSPENSION OF CLARITHROMYCIN USING ION-EXCHANGE RESINS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 3, Jan. 2020, pp. 53-60, doi:10.22159/ajpcr.2020.v13i3.36438.
Section
Original Article(s)